{"id":4721,"date":"2025-09-18T08:24:09","date_gmt":"2025-09-18T06:24:09","guid":{"rendered":"https:\/\/blog.molport.com\/?p=4721"},"modified":"2025-09-02T08:28:21","modified_gmt":"2025-09-02T06:28:21","slug":"molport-chronicles-from-alchemy-to-pharma-5","status":"publish","type":"post","link":"https:\/\/blog.molport.com\/news\/molport-chronicles-from-alchemy-to-pharma-5\/","title":{"rendered":"Molport Chronicles- from Alchemy to Pharma No.5"},"content":{"rendered":"

GSK legacy shaped by <\/span>Beecham\u2019s Pills and Research Laboratories<\/span><\/h2>\n

GSK\u2019s earliest roots<\/a> include Plough Court Pharmacy, founded in London in 1715 by Silvanus Bevan, which later evolved into Allen & Hanburys<\/a>, well known for its pioneering work in respiratory medicines. However, thanks to Beecham\u2019s Pills, launched in 1842 by Thomas Beecham (1820\u20131907), the company experienced a tremendous financial boost that\u00a0drove its early success and enabled its growth into a <\/span>primary<\/span> pharmaceutical business. These popular over-the-counter laxatives \u2014 made with ingredients like aloe, ginger, and soap \u2014 owed their effect mainly to the anthraquinones in aloe, specifically aloin (also known as barbaloin).<\/span>\u00a0<\/span><\/p>\n

In the 1950s, the Beecham company<\/a> made a <\/span>significant<\/span> leap into modern pharmaceuticals by establishing one of the world\u2019s first dedicated antibiotic research labs, becomi<\/span>ng a pioneer in penicillin<\/a> development. Beecham Research Laboratories\u2019 involvement with penicillin began with the discovery of the penicillin nucleus, 6-aminopenicillanic acid (6-APA), by its scientists in 1959 at Brockham Park<\/a><\/span>. This breakthrough<\/span> enabled the synthesis of new semisynthetic penicillins<\/span>, advancing<\/span> the field of antibiotics.<\/span>\u00a0<\/span><\/p>\n

Building on this, the Beecham company developed and marketed several <\/span>essential<\/span> penicillin-based drugs, including Broxil (phenethicillin), Celbenin (methicillin), and Penbritin (ampicillin) \u2014 firmly establishing its position as a leader in antibiotics. This remarkable evolution, from a simple patent medicine to groundbreaking antibiotic research, helped shape the legacy that lives on today as GlaxoSmithKline (GSK), one of the world\u2019s largest and most influential biopharmaceutical companies.<\/span>\u00a0<\/span><\/p>\n

\"Molport<\/p>\n

Other Molport Chronicles posts- from Alchemy to Pharma:<\/p>\n